Julie Jordan, M.D., serves as the Chief Medical Officer at NEUROGENE INC, a pioneering biotechnology company focused on developing gene therapies for neurological disorders. Dr. Jordan brings a wealth of experience and expertise to her role, having spent over two decades in the field of neurology and clinical research. She earned her medical degree from Harvard Medical School and completed her residency in neurology at Massachusetts General Hospital, one of the nation's premier medical institutions. Her passion for advancing treatments for neurological conditions has driven her career, leading her to hold key positions at several leading pharmaceutical and biotech companies before joining NEUROGENE INC. At NEUROGENE INC, Dr. Jordan plays a crucial role in overseeing the company's clinical development programs and ensuring the safety and efficacy of their innovative gene therapies. Her leadership has been instrumental in guiding the company through various stages of clinical trials, from early-phase studies to late-stage development. One of her notable achievements at NEUROGENE INC includes spearheading the successful completion of a Phase II trial for a novel gene therapy targeting a rare genetic disorder, which has shown promising results and brought hope to patients and their families. Dr. Jordan's strategic vision and commitment to scientific excellence have been pivotal in positioning NEUROGENE INC as a leader in the field of neurogenetics. Beyond her professional accomplishments, Dr. Jordan is an active member of several prestigious medical associations and frequently contributes to scientific literature, sharing her insights and findings with the broader medical community. Her dedication to improving patient outcomes and advancing the understanding of neurological diseases continues to inspire her colleagues and the patients she serves. As Chief Medical Officer at NEUROGENE INC, Dr. Julie Jordan remains at the forefront of innovation, tirelessly working to bring transformative therapies to those affected by debilitating neurological conditions.